Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neuralstem Inc (NASDAQ:CUR)

5.50
Delayed Data
As of Mar 24
 +0.05 / +0.92%
Today’s Change
2.47
Today|||52-Week Range
10.66
+54.75%
Year-to-Date
No recent news for Neuralstem Inc.

Today’s Trading

Previous close5.45
Today’s open5.46
Day’s range5.35 - 5.55
Volume82,319
Average volume (3 months)243,664
Market cap$60.7M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+11.54%
Earnings growth (this year)+19.57%
Earnings growth (next 5 years)--
Revenue growth (last year)-44.69%
P/E ratioNM
Price/Sales8,984.64
Price/Book7.84

Competitors

 Today’s
change
Today’s
% change
VSTMVerastem Inc+0.15+9.93%
KMPHKemPharm Inc-0.05-1.18%
ADMAADMA Biologics Inc-0.07-1.43%
PSDVpSivida Corp-0.00-0.01%
Data as of 3:59pm ET, 03/24/2017

Financials

Last reporting dateMarch 23, 2017
EPS forecast (this quarter)-$0.59
Annual revenue (last year)$10.4K
Annual profit (last year)-$20.9M
Net profit margin-200,671.03%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Richard J. Daly
Chief Financial Officer
Jonathan B. Lloyd Jones
Corporate headquarters
Germantown, Maryland

Forecasts


Search for Jobs